Paul B. Chapman
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Melanoma and MAPK Pathways 98
- Glycosylation and Glycoproteins Research 18
- Oncology 122
- Cutaneous Melanoma Detection and Management 54
- Cancer Immunotherapy and Biomarkers 44
- CAR-T cell therapy research 41
- Co-authors
- Katherine S. Panageas (56 shared papers)Keith T. Flaherty (21 shared papers)Antoni Ribas (21 shared papers)Jedd D. Wolchok (69 shared papers)Grant A. McArthur (22 shared papers)Jeffrey A. Sosman (12 shared papers)Alan N. Houghton (37 shared papers)K. B. Nolop (14 shared papers)
- Journals
- Journal of Clinical Oncology (66 papers)Clinical Cancer Research (13 papers)Cancer (9 papers)Melanoma Research (9 papers)American Society of Clinical Oncology Educational Book (5 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Paul B. Chapman
226 papers receiving 15.2k citations
Paul B. Chapman's Hit Papers
Peers
Comparison fields: 5 of 148
- Oncology 9.1k
- Immunology 4.1k
- Molecular Biology 8.5k
- Cancer Research 1.5k
- Ophthalmology 784
Countries citing papers authored by Paul B. Chapman
This map shows the geographic impact of Paul B. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Chapman more than expected).
Fields of papers citing papers by Paul B. Chapman
This network shows the impact of papers produced by Paul B. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Chapman. The network helps show where Paul B. Chapman may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul B. Chapman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Mutated, Activated BRAF in Metastatic Melanoma Hit paper breakdown → | 2010 | 2608 |
| 2 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Hit paper breakdown → | 2012 | 1378 |
| 3 | Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center Hit paper breakdown → | 2015 | 808 |
| 4 | Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma Hit paper breakdown → | 1999 | 542 |
| 5 | Evolutionary dynamics of cancer in response to targeted combination therapy Hit paper breakdown → | 2013 | 433 |
| 6 | 2010 | 349 | |
| 7 | Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting Hit paper breakdown → | 2010 | 344 |
| 8 | 2003 | 228 | |
| 9 | 2005 | 228 | |
| 10 | 2014 | 219 | |
| 11 | 2004 | 213 | |
| 12 | 2010 | 199 | |
| 13 | 2017 | 189 | |
| 14 | 1987 | 183 | |
| 15 | 2012 | 176 | |
| 16 | 1993 | 175 | |
| 17 | 2005 | 168 | |
| 18 | 2009 | 163 | |
| 19 | 2010 | 156 | |
| 20 | 2008 | 146 |
About Paul B. Chapman
Paul B. Chapman is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Computational Theory and Mathematics, having authored 233 papers that have together received 15.5k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (98 papers), Cutaneous Melanoma Detection and Management (54 papers), Immunotherapy and Immune Responses (50 papers), Cancer Immunotherapy and Biomarkers (44 papers), CAR-T cell therapy research (41 papers), Monoclonal and Polyclonal Antibodies Research (29 papers), Computational Drug Discovery Methods (26 papers) and Glycosylation and Glycoproteins Research (18 papers). The work is most often cited by research in Oncology (9.1k citations), Immunology (4.1k citations), Molecular Biology (8.5k citations), Cancer Research (1.5k citations) and Ophthalmology (784 citations). Paul B. Chapman has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Katherine S. Panageas, Keith T. Flaherty, Antoni Ribas, Jedd D. Wolchok, Grant A. McArthur, Jeffrey A. Sosman, Alan N. Houghton, K. B. Nolop, Igor Puzanov and Joseph F. Grippo. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Melanoma Research and American Society of Clinical Oncology Educational Book.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.